Keywords
How to Cite
Abstract
Germ cell neoplasms in the group of benign and malignant tumors heterogeneous in morphological structure, clinical features and prognosis. A special characteristic of germ cell tumors is their high sensitivity to platinum-containing chemotherapy, which allows cure of up to 80–90% patients. However 20–25% of patients with a common type have overall survival rate of less than 50%.
The aim of the study is to assess the survival rate of children with extracranial germ cell tumors and to identify adverse risk factors.
Methods. The study includes 116 children with extracranial germ cell tumors treated from 2013 to September 2009. Treatment consisted of tumor resection and platinum based on platinum chemotherapy. Survival rate was assessed by the Kaplan-Mayer method. Prognostic factors are determined according to IGCCCG, MaGIC, MAKEI, RODO.
Results. Overall and event free survival rates were 79±5% and 76±4%, respectively. The worst overall survival had patients with extragonadal tumors, advanced stages of a disease, high initial level of AFP (≥10 000 ng/ml), non-seminoma version of state treasury bills and extra pulmonary metastases.
Conclusion. Survival rate in children with extracranial germ cell tumors depends on the prognostic factors. Statistically significant predictors of the poor prognosis were extragonadal localization of a tumor and the AFP level ≥10 000 ng/ml.
References
PierceJL, Frazier AL, Amatruda JF. Pediatric Germ Cell Tumors: A Developmental Perspective // Hindawi. Advances in urology. 2018, Article ID 9059382. doi:10.1155/2018/9059382
Murray MJ, Nicholson JC. Germ cell tumors in children and adolescents // Paediatrics and Child Health. 2010;20(3):109–116. doi:10.1016/j.paed.2009.10.006
Oosterhuis W, Looijenga LH. Testicular germ-cell tumors in a broader perspective // Nature Reviews Cancer. 2005;5(3):210–222.
Olson TA, Murray MJ et al. Pediatric and Adolescent Extracranial Germ Cell Tumors: The Road to Collaboration // Journal of Clinical Oncology. 2015;33(27):3018–3028. doi:10.1200/JCO.2014.60.5337
Frazier AL, Hale JP, Rodriguez-Galindo C et al. Revised risk classification for pediatric extracranial germ cell tumors based on 25 years of clinical trial data from the United Kingdom and United States // J Clin Oncol. 2015;33(2):195–201. doi:10.1200/JCO.2014.58.3369
Frazier AL, Stoneham S, Rodriguez-Galindo C et al. Comparison of carboplatin versus cisplatin in the treatment of paediatric extracranial malignant germ cell tumours: A report of the Malignant Germ Cell International Consortium // Eur J Cancer. 2018;98:30–37. doi:10.1016/j.ejca.2018.03.004. Epub 2018 May 31
Hou JY, Liu HC, Yeh TC et al. Treatment Results of Extracranial Malignant Germ Cell Tumor with Regimens of Cisplatin, Vinblastine, Bleomycin or Carboplatin, Etoposide, and Bleomycin with Special Emphasis on the Sites of Vagina and Testis // Pediatr Neonatol. 2015;56(5):301–6. doi:10.1016/j.pedneo.2014.12.003. Epub 2015 Feb 2
Singh R, Fazal Z, Freemantle SJ, Spinella MJ. Mechanisms of cisplatin sensitivity and resistance in testicular germ cell tumors // Cancer Drug Resistance. 2019;2:580–94. doi:10.20517/cdr.2019.19
International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group // J Clin Oncol. 1997;15:594–603.
Marina N, London WB, Frazier AL et al. Prognostic factors in children with extragonadal malignant germ cell tumors: a pediatric intergroup study // J Clin Oncol. 2006;24:2544–8.
Jinsup Kim, Na Hee Lee et al. Prognostic factors in children with extracranial germ cell tumors treated with cisplatin-based chemotherapy // Korean J Pediatr. 2015;58(10):386–391. doi:10.3345/kjp.2015.58.10.386
Zubizarreta P, Rossa A, Bailez M et al. Malignant extra-cranial germ cell tumors in children and adolescents. Results following the guidelines of SFOP/SFCE 95 Protocol // Medicina (B Aires). 2016;76(5):265–272.
Fedhila F, Rhayem S, Hafsi H et al. Prognostic factors in children with extracranial malignant germ cell tumors: a monocentric pediatric Tunisian study // Tunis Med. 2016;94(4):309–314.
Winter C, Pfister D, Busch J et al. Residual tumor size and IGCCCG risk classification predict additional vascular procedures in patients with germ cell tumors and residual tumor resection: a multicenter analysis of the German Testicular Cancer Study Group // Eur Urol. 2012;61(2):403–9. doi:10.1016/j.eururo.2011.10.045. Epub 2011 Nov 7
Kollmannsberger C, Nichols C, Meisner C et al. Identification of prognostic subgroups among patients with metastatic 'IGCCCG poor-prognosis' germ-cell cancer: an explorative analysis using cart modeling // Ann Oncol. 2000;11(9):1115–20.
Frazier AL, Rumcheva P, Olson T et al. Application of the adult international germ cell classification system to pediatric malignant non-seminomatous germ cell tumors: a report from the Children's Oncology Group // Pediatr Blood Cancer. 2008;50:746–51.
Calaminus G, Schneider DT, Bokkerink JP et al. Prognostic value of tumor size, metastases, extension into bone, and increased tumor marker in children with malignant sacrococcygeal germ cell tumors: a prospective evaluation of 71 patients treated in the German cooperative protocols Maligne Keimzelltumoren (MAKEI) 83/86 and MAKEI 89 // J Clin Oncol 2003;21:781–6.
Depani S, Stoneham S, Krailo M et al. Results from the UK Children's Cancer and Leukaemia Group study of extracranial germ cell tumours in children and adolescents (GCIII) // Eur J Cancer. 2019;118:49–57. doi:10.1016/j.ejca.2019.05.001
Нечушкина И.В. Клинические рекомендации по диагностике и лечению детей, больных герминогенными опухолями. М., 2014.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
© АННМО «Вопросы онкологии», Copyright (c) 2021